We've changed the way you complete courses
In response to user feedback we have simplified the way courses can be completed.
Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.
Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.
Once you have completed all of the topics in a module an assessment will be provided for you.
Complete all the assessments to finish the course.
From obscure origins in studies of lizard saliva, GLP-1 receptor agonists (GLP-1RAs) have become a staple of type 2 diabetes treatment. This course examines the ways in which they can aid type 2 diabetes management.
In module one, we introduce you to the incretin hormone GLP-1 (glucagon-like peptide-1), its physiology, pathophysiology and mechanisms of action. We also appraise trial data on the use of GLP-1RAs to treat type 2 diabetes.
In module two, we take a closer look at the role GLP-1 plays in the cardiovascular system and the therapeutic potential of GLP-1RAs to improve cardiovascular outcomes in people with type 2 diabetes.
Module 3 takes a closer look at the potential use of GLP-1RAs to treat obesity and its complications, with particular focus on non-alcohol related fatty liver disease (NAFLD) and non-alcohol related steatohepatitis (NASH).